APPLICATION
ANDA076171
TYPE
ANDA
ORIGINAL APPROVAL
2005-04-08
LATEST ACTION
2020-04-27
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued
Products
MOMETASONE FUROATEDiscontinued
MOMETASONE FUROATE 0.1% · CREAM · TOPICAL
Approval history
2020-04-27Labeling · Supplement 4 · standardAP
2015-11-10Labeling · Supplement 3 · standardAP
2005-04-08OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.